Digoxin inhibits development of hypoxic pulmonary hypertension in mice

scientific article published on 9 January 2012

Digoxin inhibits development of hypoxic pulmonary hypertension in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2012PNAS..109.1239A
P356DOI10.1073/PNAS.1120385109
P932PMC publication ID3268303
P698PubMed publication ID22232678
P5875ResearchGate publication ID221736131

P50authorGregg L. SemenzaQ1545025
P2093author name stringJ T Sylvester
Larissa A Shimoda
Allen C Myers
Ari L Zaiman
Clark Undem
Edsel M Abud
Julie Maylor
Arjun Punjabi
P2860cites workHIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensingQ24291102
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tensionQ24307473
A new mathematical model for relative quantification in real-time RT-PCRQ27860781
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylationQ27860876
Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cellsQ28257426
Hypoxia-inducible factors in the kidneyQ28303287
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alphaQ28508120
Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytesQ28566041
Sodium-hydrogen exchange inhibition attenuates glycoside-induced hypertrophy in rat ventricular myocytesQ28568918
An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertensionQ28576675
Purification and characterization of hypoxia-inducible factor 1Q28678375
Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growthQ33385608
Divergent cardiopulmonary actions of heme oxygenase enzymatic products in chronic hypoxia.Q33471430
Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularizationQ33868764
Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularizationQ35006577
Cellular and molecular pathobiology of pulmonary arterial hypertensionQ35803229
Differences in STIM1 and TRPC expression in proximal and distal pulmonary arterial smooth muscle are associated with differences in Ca2+ responses to hypoxiaQ36808053
Hypoxia and chronic lung disease.Q37015304
The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice.Q37403106
Cellular and molecular basis of pulmonary arterial hypertensionQ37465320
HIF and the lung: role of hypoxia-inducible factors in pulmonary development and diseaseQ37829597
Some aspects of pharmacokinetic and biotransformation differences in humans and mammal animalsQ39618312
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampinQ40851439
The use of digitalis in patients with pulmonary diseaseQ41386466
Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cellsQ42495592
Hypoxic pulmonary vasoconstriction in intact rat intrapulmonary arteries is not initiated by inhibition of Na+-Ca2+ exchangeQ42515420
The effect of digoxin on cardiovascular responses to hypoxia and reoxygenation in anesthetized dogs.Q51861189
Partial inhibition of Na+/K+-ATPase by ouabain induces the Ca2+-dependent expressions of early-response genes in cardiac myocytes.Q52201951
HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes.Q53618498
Stimulation of vascular smooth muscle sodium, potassium--adenosinetriphosphatase by vasodilators.Q53752982
Cellular Mechanisms that Control Pulmonary Vascular Tone during Hypoxia and Normoxia: Possible Role of Ca2+ATPasesQ54269957
Calcium-induced pulmonary vasodilation: modification by meclofenamate and ouabainQ70391511
Hypoxia impairs nitrovasodilator-induced pulmonary vasodilation: role of Na-K-ATPase activityQ71404735
Digitalis intoxication. A prospective clinical study with serum level correlationsQ71780262
Mechanisms of hypoxic vasoconstriction in the canine isolated pulmonary artery: role of endothelium and sodium pumpQ72158643
L-type Ca(2+) channels, resting [Ca(2+)](i), and ET-1-induced responses in chronically hypoxic pulmonary myocytesQ73127465
Role of Na(+)-K(+)-ATPase in sodium nitroprusside-induced relaxation of pulmonary artery under hypoxiaQ73712393
Differential regulation of Na/K-ATPase alpha-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuliQ73955503
Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxiaQ74014913
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesisQ74845878
The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertensionQ77318711
Pulmonary hypertensionQ80884934
P433issue4
P407language of work or nameEnglishQ1860
P921main subjecthypoxiaQ105688
digoxinQ422222
pulmonary hypertensionQ1128595
P304page(s)1239-1244
P577publication date2012-01-09
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleDigoxin inhibits development of hypoxic pulmonary hypertension in mice
P478volume109

Reverse relations

cites work (P2860)
Q42413284"A small leak will sink a great ship": hypoxia-inducible factor and group III pulmonary hypertension
Q26741122"Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols
Q4241517855th Bowditch Lecture: Effects of chronic hypoxia on the pulmonary circulation: role of HIF-1.
Q46280881A Brief Overview of Nitric Oxide and Reactive Oxygen Species Signaling in Hypoxia-Induced Pulmonary Hypertension
Q27026643A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?
Q36764714Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1.
Q37487004Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.
Q37054481Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.
Q94560908Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
Q91997820Digoxin Attenuates Receptor Activation of NF-κB Ligand-Induced Osteoclastogenesis in Macrophages
Q28397747Digoxin downregulates NDRG1 and VEGF through the inhibition of HIF-1α under hypoxic conditions in human lung adenocarcinoma A549 cells
Q36041722Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury
Q33723858Effects of 17β-estradiol and 2-methoxyestradiol on the oxidative stress-hypoxia inducible factor-1 pathway in hypoxic pulmonary hypertensive rats
Q35887239Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling
Q37679350HIF and pulmonary vascular responses to hypoxia
Q36810837Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development
Q33920050Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension
Q36178060Hypoxia-induced migration in pulmonary arterial smooth muscle cells requires calcium-dependent upregulation of aquaporin 1
Q47292596Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease
Q36068993Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
Q37057231Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases
Q92984589Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension
Q36717280Low ambient oxygen prevents atherosclerosis
Q38804579Lung Circulation
Q89344744Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension
Q38558147Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension
Q49203906Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".
Q35665720Na(+)/H(+) exchange and hypoxic pulmonary hypertension
Q38128383Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology
Q36902375Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension
Q90963815Pharmacologic Targeting of Hypoxia-Inducible Factors
Q90625006Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia
Q40374764Protective effects of heat shock protein 70 against hypoxic pulmonary hypertension in neonatal rats
Q37555431Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series).
Q37688525Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.
Q39710763Role of Rho kinase and Na+/H+ exchange in hypoxia-induced pulmonary arterial smooth muscle cell proliferation and migration
Q35115789The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes
Q89167704Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor
Q35686329Upregulation of canonical transient receptor potential channel in the pulmonary arterial smooth muscle of a chronic thromboembolic pulmonary hypertension rat model.
Q36644607Vascular remodeling in pulmonary hypertension
Q47602826Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension
Q37556377miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation

Search more.